Literature DB >> 28361356

[Pathophysiology of atopic blepharokeratoconjunctivitis].

T Lapp1, P Maier2, T Jakob3, T Reinhard2.   

Abstract

Atopic dermatitis (AD) is a systemic inflammatory disease, which is characterized by pronounced eczema and pruritus. In addition to the involvement of the entire integument, the periocular lid skin and the surface of the eye are frequently involved. Ocular involvement may occur solely without dermatitis of facial or body skin. Pathophysiologically, besides a dysregulated immune response, genetic changes can occur in various dermal structural proteins which will lead to a disturbed skin barrier. Furthermore, there is a regular colonization with bacterial pathogens and an increased susceptibility for viral skin infections. The lid margin reveals a loss of Meibomian glands whereas the conjunctiva shows reduced goblet cells. Consecutively, eye surface defects and recurrent conjunctival and corneal defects can be found. Increased mechanical manipulation in atopia-associated pruritus is seen as a cause of increased comorbidity with keratoconus. In addition, individual cases are reported of various malignomas of the eye surface, which are present in patients with AD. Understanding of the pathophysiological connections is essential for the correct diagnosis and therapy of this clinically very complex disease picture.

Entities:  

Keywords:  Atopic dermatitis; Conjunctival intraepithelial neoplasms; Filaggrin; Keratoconus; Neurodermitis

Mesh:

Year:  2017        PMID: 28361356     DOI: 10.1007/s00347-017-0483-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  84 in total

1.  Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection.

Authors:  Alexander A Navarini; Lars E French; Günther F L Hofbauer
Journal:  J Allergy Clin Immunol       Date:  2011-10-01       Impact factor: 10.793

2.  Periorbital Hyperpigmentation: A Comprehensive Review.

Authors:  Rashmi Sarkar; Rashmi Ranjan; Shilpa Garg; Vijay K Garg; Sidharth Sonthalia; Shivani Bansal
Journal:  J Clin Aesthet Dermatol       Date:  2016-01

3.  Atopic keratoconjunctivitis.

Authors:  Y A Akova; A Rodriguez; C S Foster
Journal:  Ocul Immunol Inflamm       Date:  1994       Impact factor: 3.070

4.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

5.  Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis.

Authors:  T Werfel; A Morita; M Grewe; H Renz; U Wahn; J Krutmann; A Kapp
Journal:  J Invest Dermatol       Date:  1996-12       Impact factor: 8.551

6.  Filaggrin in the frontline: role in skin barrier function and disease.

Authors:  Aileen Sandilands; Calum Sutherland; Alan D Irvine; W H Irwin McLean
Journal:  J Cell Sci       Date:  2009-05-01       Impact factor: 5.285

7.  Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus.

Authors:  Michael D Howell; Richard L Gallo; Mark Boguniewicz; James F Jones; Cathy Wong; Joanne E Streib; Donald Y M Leung
Journal:  Immunity       Date:  2006-03       Impact factor: 31.745

Review 8.  Atopic keratoconjunctivitis: A review.

Authors:  Joseph J Chen; Danielle S Applebaum; Grace S Sun; Stephen C Pflugfelder
Journal:  J Am Acad Dermatol       Date:  2013-12-15       Impact factor: 11.527

9.  Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

Authors:  Diamant Thaçi; Eric L Simpson; Lisa A Beck; Thomas Bieber; Andrew Blauvelt; Kim Papp; Weily Soong; Margitta Worm; Jacek C Szepietowski; Howard Sofen; Makoto Kawashima; Richard Wu; Steven P Weinstein; Neil M H Graham; Gianluca Pirozzi; Ariel Teper; E Rand Sutherland; Vera Mastey; Neil Stahl; George D Yancopoulos; Marius Ardeleanu
Journal:  Lancet       Date:  2015-10-08       Impact factor: 79.321

Review 10.  Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

Authors:  Mark Boguniewicz; Donald Y M Leung
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

View more
  3 in total

1.  MACE RNA sequencing analysis of conjunctival squamous cell carcinoma and papilloma using formalin-fixed paraffin-embedded tumor tissue.

Authors:  Stefaniya Boneva; Anja Schlecht; Peipei Zhang; Daniel Boehringer; Thabo Lapp; Hans Mittelviefhaus; Thomas Reinhard; Claudia Auw-Haedrich; Guenther Schlunck; Julian Wolf; Clemens Lange
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

2.  Assessment of Meibomian Gland (MD) Impairment Among Seasonal Allergic Conjunctivitis (SAC) Patients.

Authors:  Limei Liu; Jiaomin Yang; Wuguang Ji; Chao Wang
Journal:  Med Sci Monit       Date:  2022-04-05

3.  Serum 25-Hydroxyvitamin D, Selenium, Zinc and Copper in Patients with Keratoconus.

Authors:  Siamak Zarei-Ghanavati; Bahareh Yahaghi; Samira Hassanzadeh; Majid Ghayour Mobarhan; Hamid Reza Hakimi; Pardis Eghbali
Journal:  J Curr Ophthalmol       Date:  2020-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.